Note: Ingredients listed on restricted chemical lists
EC/CAS
1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
215-222-5
Name of the chemical
Zinc oxide (2)
Concentration
N/A
EC/CAS
236-675-5
Name of the chemical
Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)
Concentration
N/A
General Information
Revision date
2022-03-04
Product name
Caltrate MINIs Plus Minerals Tablets
Product Synonyms
WH-1595-0001 * CALTRATE MINIS PLUS MINERALS * H000006621
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Hazard Codes
Hazard statements (CLP)
H411
Hazard statements
Code
Statements
H411
Toxic to aquatic life with long lasting effects
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Environmental hazards
Hazardous to the aquatic environment, Category 2 H411 - Toxic to aquatic life with long-term aquatic hazard long lasting effects. Hazard summary Prolonged exposure may cause chronic effects. Dangerous for the environment if discharged into watercourses. Not classified for health hazards. However, occupational exposure to the mixture or substance(s) may cause adverse health effects.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Signal word
None.
Hazard statements
H411 Toxic to aquatic life with long lasting effects.
Prevention
P273 Avoid release to the environment.
Response
P391 Collect spillage.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
10.6 % of the mixture consists of component(s) of unknown acute oral toxicity. 15 % of the mixture consists of component(s) of unknown acute dermal toxicity. 15 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment.
2.3 Other hazards
This mixture does not contain substances assessed to be vPvB / PBT according to Regulation (EC) No 1907/2006, Annex XIII. The product does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
